What is the treatment for leukodystrophy?
What is the treatment for leukodystrophy?
A stem cell or bone marrow transplant may improve some types of leukodystrophy. Chenodeoxycholic acid (CDCA) replacement therapy can treat CTX if it’s diagnosed early. CTX is currently the only treatable form of leukodystrophy.
What is the life expectancy of someone with leukodystrophy?
Children diagnosed with late infantile MLD typically live another five to 10 years. In juvenile MLD, the life expectancy is 10 to 20 years after diagnosis. If the symptoms don’t appear until adulthood, people typically live 20 to 30 years after the diagnosis.
What is FMLD disease?
Summary. Listen. Metachromatic leukodystrophy is an inherited condition characterized by the accumulation of fats called sulfatides in cells , especially cells of the nervous system. This accumulation results in progressive destruction of white matter of the brain, which consists of nerve fibers covered by myelin .
Can leukodystrophy affect the brain?
Leukodystrophy refers to a group of genetic conditions that affect the white matter of the brain. Leukodystrophy causes loss of normal brain functions. Symptoms of leukodystrophy can vary. Most leukodystrophies do not have a cure, but therapies are being developed that can help stop the condition from getting worse.
When does MLD start?
Juvenile MLD typically appears between ages 4 and 12. Adult MLD can begin during the teen years, but in some people may not appear until the 40s or 50s. Diagnosing MLD usually involves MRI scans of the brain, which typically show changes in the myelin sheath and nerve fibers (white matter) of the brain’s hemispheres.
How do you test for MLD?
The diagnosis of MLD is made through both genetic and biochemical testing. Genetic testing can identify mutations in the ASA and PSAP genes. Biochemical testing includes sulfatase enzyme activity and urinary sulfatide excretion. An MRI can confirm a diagnosis of MLD.
What enzyme is deficient in metachromatic leukodystrophy?
The most common cause of metachromatic leukodystrophy is a mutation in the ARSA gene. This mutation results in a lack of the enzyme that breaks down lipids called sulfatides that build up in the myelin.
